PEPTIDES for Veterans Act

The PEPTIDES for Veterans Act directs the Secretary of Veterans Affairs to review existing federal regulations regarding peptides and submit a report within 180 days that establishes specific definitions for peptides and peptide-based therapies. Following this initial review, the Department must conduct an 18-month study on the safety and efficacy of these treatments for veterans, focusing on conditions such as chronic pain, mental health, and rehabilitation needs. If the study concludes that these therapies should be made available, the Secretary is required to launch a pilot program lasting up to five years to evaluate their effectiveness in real-world clinical settings. The bill ultimately aims to determine whether peptide-based therapies can be integrated into standard care for veterans based on the findings from the mandated research and pilot evaluation.